1. |
ACMSD |
ENSG00000153086 |
12 |
2 |
1.000 |
1.000 |
aminocarboxymuconate semialdehyde decarboxylase [Source:HGNC Symbol;Acc:HGNC:19288] |
2. |
ACE2 |
ENSG00000130234 |
9 |
1.78 |
0.804 |
0.976 |
angiotensin I converting enzyme 2 [Source:HGNC Symbol;Acc:HGNC:13557] |
3. |
DIO1 |
ENSG00000211452 |
26 |
1.65 |
0.831 |
0.819 |
iodothyronine deiodinase 1 [Source:HGNC Symbol;Acc:HGNC:2883] |
4. |
CPN1 |
ENSG00000120054 |
18 |
1.623 |
0.804 |
0.819 |
carboxypeptidase N subunit 1 [Source:HGNC Symbol;Acc:HGNC:2312] |
5. |
LIPC |
ENSG00000166035 |
166 |
1.507 |
0.763 |
0.744 |
lipase C, hepatic type [Source:HGNC Symbol;Acc:HGNC:6619] |
6. |
F2 |
ENSG00000180210 |
105 |
1.469 |
0.711 |
0.758 |
coagulation factor II, thrombin [Source:HGNC Symbol;Acc:HGNC:3535] |
7. |
UPK3A |
ENSG00000100373 |
5 |
0.983 |
- |
0.983 |
uroplakin 3A [Source:HGNC Symbol;Acc:HGNC:12580] |
8. |
KRT6A |
ENSG00000205420 |
3 |
0.983 |
- |
0.983 |
keratin 6A [Source:HGNC Symbol;Acc:HGNC:6443] |
9. |
LINC01317 |
|
3 |
0.983 |
- |
0.983 |
long intergenic non-protein coding RNA 1317 |
10. |
ENPP7 |
ENSG00000182156 |
3 |
0.983 |
- |
0.983 |
ectonucleotide pyrophosphatase/phosphodiesterase 7 [Source:HGNC Symbol;Acc:HGNC:23764] |
11. |
TXNDC2 |
ENSG00000168454 |
6 |
0.983 |
- |
0.983 |
thioredoxin domain containing 2 [Source:HGNC Symbol;Acc:HGNC:16470] |
12. |
F11 |
ENSG00000088926 |
3 |
0.983 |
- |
0.983 |
coagulation factor XI [Source:HGNC Symbol;Acc:HGNC:3529] |
13. |
SH3PXD2A-AS1 |
ENSG00000280693 |
10 |
0.983 |
- |
0.983 |
SH3PXD2A antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:45242] |
14. |
LMNTD1 |
ENSG00000152936 |
16 |
0.981 |
- |
0.981 |
lamin tail domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26683] |
15. |
LINC01305 |
ENSG00000231453 |
48 |
0.98 |
- |
0.980 |
long intergenic non-protein coding RNA 1305 [Source:HGNC Symbol;Acc:HGNC:27690] |
16. |
RASGRF2-AS1 |
ENSG00000251450 |
9 |
0.978 |
- |
0.978 |
RASGRF2 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:40499] |
17. |
DHRS2 |
ENSG00000100867 |
4 |
0.978 |
- |
0.978 |
dehydrogenase/reductase 2 [Source:HGNC Symbol;Acc:HGNC:18349] |
18. |
LOC100506406 |
|
4 |
0.977 |
- |
0.977 |
uncharacterized LOC100506406 |
19. |
C7orf76 |
|
5 |
0.976 |
- |
0.976 |
chromosome 7 open reading frame 76, transcript variant 2 |
20. |
CYP3A7-CYP3A51P |
ENSG00000282301 |
5 |
0.975 |
- |
0.975 |
CYP3A7-CYP3A51P readthrough [Source:HGNC Symbol;Acc:HGNC:51504] |
21. |
F12 |
ENSG00000131187 |
17 |
0.971 |
- |
0.971 |
coagulation factor XII [Source:HGNC Symbol;Acc:HGNC:3530] |
22. |
C2-AS1 |
ENSG00000281756 |
6 |
0.966 |
- |
0.966 |
C2 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:49464] |
23. |
SLC6A19 |
ENSG00000174358 |
22 |
0.965 |
- |
0.965 |
solute carrier family 6 member 19 [Source:HGNC Symbol;Acc:HGNC:27960] |
24. |
HYAL1 |
ENSG00000114378 |
94 |
0.963 |
- |
0.963 |
hyaluronoglucosaminidase 1 [Source:HGNC Symbol;Acc:HGNC:5320] |
25. |
LOC101929473 |
|
4 |
0.963 |
- |
0.963 |
uncharacterized LOC101929473 |
26. |
GRAP2 |
ENSG00000100351 |
49 |
0.962 |
- |
0.962 |
GRB2 related adaptor protein 2 [Source:HGNC Symbol;Acc:HGNC:4563] |
27. |
PATE4 |
ENSG00000237353 |
6 |
0.956 |
- |
0.956 |
prostate and testis expressed 4 [Source:HGNC Symbol;Acc:HGNC:35427] |
28. |
LOC101928942 |
|
4 |
0.953 |
- |
0.953 |
uncharacterized LOC101928942 |
29. |
SUGT1P1 |
ENSG00000226823 |
47 |
0.95 |
- |
0.950 |
SUGT1 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:19384] |
30. |
GBP7 |
ENSG00000213512 |
7 |
0.946 |
- |
0.946 |
guanylate binding protein 7 [Source:HGNC Symbol;Acc:HGNC:29606] |
31. |
LPA |
ENSG00000198670 |
8 |
0.944 |
- |
0.944 |
lipoprotein(a) [Source:HGNC Symbol;Acc:HGNC:6667] |
32. |
HLA-H |
ENSG00000206341, ENSG00000223463, ENSG00000226893, ENSG00000227296, ENSG00000227669, ENSG00000231904, ENSG00000237218, ENSG00000247700 |
46 |
0.942 |
- |
0.942 |
major histocompatibility complex, class I, H (pseudogene) [Source:HGNC Symbol;Acc:HGNC:4965] |
33. |
VSIG2 |
ENSG00000019102 |
17 |
0.941 |
- |
0.941 |
V-set and immunoglobulin domain containing 2 [Source:HGNC Symbol;Acc:HGNC:17149] |
34. |
POLN |
ENSG00000130997 |
39 |
0.937 |
- |
0.937 |
DNA polymerase nu [Source:HGNC Symbol;Acc:HGNC:18870] |
35. |
LINC01068 |
ENSG00000227676 |
8 |
0.937 |
- |
0.937 |
long intergenic non-protein coding RNA 1068 [Source:HGNC Symbol;Acc:HGNC:49106] |
36. |
GPT |
ENSG00000167701 |
6 |
0.936 |
- |
0.936 |
glutamic--pyruvic transaminase [Source:HGNC Symbol;Acc:HGNC:4552] |
37. |
CD38 |
ENSG00000004468 |
8 |
0.936 |
- |
0.936 |
CD38 molecule [Source:HGNC Symbol;Acc:HGNC:1667] |
38. |
PRODH2 |
ENSG00000250799 |
33 |
0.931 |
- |
0.931 |
proline dehydrogenase 2 [Source:HGNC Symbol;Acc:HGNC:17325] |
39. |
KRT6C |
ENSG00000170465 |
4 |
0.929 |
- |
0.929 |
keratin 6C [Source:HGNC Symbol;Acc:HGNC:20406] |
40. |
C8A |
ENSG00000157131 |
23 |
0.928 |
- |
0.928 |
complement C8 alpha chain [Source:HGNC Symbol;Acc:HGNC:1352] |
41. |
CCL21 |
ENSG00000137077 |
19 |
0.927 |
0.927 |
- |
C-C motif chemokine ligand 21 [Source:HGNC Symbol;Acc:HGNC:10620] |
42. |
LOC284950 |
|
10 |
0.927 |
0.927 |
- |
uncharacterized LOC284950 |
43. |
TNFAIP8L2 |
ENSG00000163154 |
5 |
0.924 |
- |
0.924 |
TNF alpha induced protein 8 like 2 [Source:HGNC Symbol;Acc:HGNC:26277] |
44. |
TMEM82 |
ENSG00000162460 |
5 |
0.921 |
- |
0.921 |
transmembrane protein 82 [Source:HGNC Symbol;Acc:HGNC:32350] |
45. |
LOC613037 |
|
10 |
0.917 |
- |
0.917 |
nuclear pore complex interacting protein member, transcript variant X9 |
46. |
CCDC116 |
ENSG00000161180 |
9 |
0.914 |
- |
0.914 |
coiled-coil domain containing 116 [Source:HGNC Symbol;Acc:HGNC:26688] |
47. |
LECT2 |
ENSG00000145826 |
19 |
0.908 |
- |
0.908 |
leukocyte cell derived chemotaxin 2 [Source:HGNC Symbol;Acc:HGNC:6550] |
48. |
SERPINA1 |
ENSG00000197249, ENSG00000277377 |
1757 |
0.896 |
- |
0.896 |
serpin family A member 1 [Source:HGNC Symbol;Acc:HGNC:8941] |
49. |
UPK3BL |
|
5 |
0.896 |
- |
0.896 |
uroplakin 3B-like |
50. |
AGT |
ENSG00000135744 |
990 |
0.895 |
- |
0.895 |
angiotensinogen [Source:HGNC Symbol;Acc:HGNC:333] |
51. |
TFF2 |
ENSG00000160181 |
4 |
0.893 |
- |
0.893 |
trefoil factor 2 [Source:HGNC Symbol;Acc:HGNC:11756] |
52. |
NEURL3 |
ENSG00000163121 |
13 |
0.893 |
- |
0.893 |
neuralized E3 ubiquitin protein ligase 3 [Source:HGNC Symbol;Acc:HGNC:25162] |
53. |
ARSG |
ENSG00000141337 |
72 |
0.88 |
- |
0.880 |
arylsulfatase G [Source:HGNC Symbol;Acc:HGNC:24102] |
54. |
LDLRAD4-AS1 |
ENSG00000267690 |
5 |
0.879 |
- |
0.879 |
LDLRAD4 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:48592] |
55. |
ADAM21 |
ENSG00000139985 |
9 |
0.876 |
- |
0.876 |
ADAM metallopeptidase domain 21 [Source:HGNC Symbol;Acc:HGNC:200] |
56. |
LINC01094 |
ENSG00000251442 |
47 |
0.875 |
- |
0.875 |
long intergenic non-protein coding RNA 1094 [Source:HGNC Symbol;Acc:HGNC:49219] |
57. |
CD72 |
ENSG00000137101 |
20 |
0.871 |
- |
0.871 |
CD72 molecule [Source:HGNC Symbol;Acc:HGNC:1696] |
58. |
SLC17A2 |
ENSG00000112337 |
5 |
0.871 |
- |
0.871 |
solute carrier family 17 member 2 [Source:HGNC Symbol;Acc:HGNC:10930] |
59. |
PPP4R1L |
ENSG00000124224 |
8 |
0.868 |
- |
0.868 |
protein phosphatase 4 regulatory subunit 1 like (pseudogene) [Source:HGNC Symbol;Acc:HGNC:15755] |
60. |
APOC3 |
ENSG00000110245 |
58 |
0.848 |
- |
0.848 |
apolipoprotein C3 [Source:HGNC Symbol;Acc:HGNC:610] |
61. |
DEGS2 |
ENSG00000168350 |
37 |
0.848 |
0.848 |
- |
delta 4-desaturase, sphingolipid 2 [Source:HGNC Symbol;Acc:HGNC:20113] |
62. |
APCDD1L |
ENSG00000198768 |
86 |
0.842 |
- |
0.842 |
APC down-regulated 1 like [Source:HGNC Symbol;Acc:HGNC:26892] |
63. |
TSPAN8 |
ENSG00000127324 |
35 |
0.841 |
- |
0.841 |
tetraspanin 8 [Source:HGNC Symbol;Acc:HGNC:11855] |
64. |
NR4A3 |
ENSG00000119508 |
52 |
0.834 |
- |
0.834 |
nuclear receptor subfamily 4 group A member 3 [Source:HGNC Symbol;Acc:HGNC:7982] |
65. |
C4BPB |
ENSG00000123843 |
8 |
0.832 |
- |
0.832 |
complement component 4 binding protein beta [Source:HGNC Symbol;Acc:HGNC:1328] |
66. |
GSTA1 |
ENSG00000243955 |
75 |
0.832 |
- |
0.832 |
glutathione S-transferase alpha 1 [Source:HGNC Symbol;Acc:HGNC:4626] |
67. |
HSD17B2 |
ENSG00000086696 |
27 |
0.826 |
0.826 |
- |
hydroxysteroid 17-beta dehydrogenase 2 [Source:HGNC Symbol;Acc:HGNC:5211] |
68. |
KLB |
ENSG00000134962 |
179 |
0.825 |
- |
0.825 |
klotho beta [Source:HGNC Symbol;Acc:HGNC:15527] |
69. |
GTSE1-AS1 |
|
26 |
0.822 |
- |
0.822 |
GTSE1 antisense RNA 1 (head to head) |
70. |
SLC38A3 |
ENSG00000188338 |
66 |
0.821 |
- |
0.821 |
solute carrier family 38 member 3 [Source:HGNC Symbol;Acc:HGNC:18044] |
71. |
TTR |
ENSG00000118271 |
2112 |
0.82 |
- |
0.820 |
transthyretin [Source:HGNC Symbol;Acc:HGNC:12405] |
72. |
GNRHR2 |
ENSG00000211451 |
45 |
0.813 |
- |
0.813 |
gonadotropin releasing hormone receptor 2 (pseudogene) [Source:HGNC Symbol;Acc:HGNC:16341] |
73. |
PTGS2 |
ENSG00000073756 |
44 |
0.805 |
- |
0.805 |
prostaglandin-endoperoxide synthase 2 [Source:HGNC Symbol;Acc:HGNC:9605] |
74. |
LOC100505739 |
LOC100505739 |
3 |
0.804 |
0.804 |
- |
|
75. |
BCAR4 |
ENSG00000262117 |
6 |
0.804 |
0.804 |
- |
breast cancer anti-estrogen resistance 4 [Source:HGNC Symbol;Acc:HGNC:22170] |
76. |
CACNA1I |
ENSG00000100346 |
9 |
0.804 |
0.804 |
- |
calcium voltage-gated channel subunit alpha1 I [Source:HGNC Symbol;Acc:HGNC:1396] |
77. |
LOC101927482 |
|
7 |
0.804 |
0.804 |
- |
uncharacterized LOC101927482, transcript variant 2 |
78. |
ITFG1-AS1 |
ENSG00000260281 |
3 |
0.804 |
0.804 |
- |
ITFG1 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:51383] |
79. |
TRY2P |
ENSG00000186163, ENSG00000282170 |
2 |
0.804 |
0.804 |
- |
trypsinogen-like pseudogene [Source:NCBI gene;Acc:207147] |
80. |
PIGR |
ENSG00000162896 |
4 |
0.804 |
0.804 |
- |
polymeric immunoglobulin receptor [Source:HGNC Symbol;Acc:HGNC:8968] |
81. |
ANKRD30B |
ENSG00000180777 |
9 |
0.804 |
0.804 |
- |
ankyrin repeat domain 30B [Source:HGNC Symbol;Acc:HGNC:24165] |
82. |
FER1L6 |
ENSG00000214814 |
1 |
0.804 |
0.804 |
- |
fer-1 like family member 6 [Source:HGNC Symbol;Acc:HGNC:28065] |
83. |
MEI4 |
ENSG00000269964 |
2 |
0.804 |
0.804 |
- |
meiotic double-stranded break formation protein 4 [Source:HGNC Symbol;Acc:HGNC:43638] |
84. |
LOC101929095 |
|
1 |
0.804 |
0.804 |
- |
uncharacterized LOC101929095 |
85. |
KRTAP5-2 |
ENSG00000205867, ENSG00000278489, ENSG00000281533 |
2 |
0.804 |
0.804 |
- |
keratin associated protein 5-2 [Source:HGNC Symbol;Acc:HGNC:23597] |
86. |
PSMB8-AS1 |
ENSG00000204261, ENSG00000206232, ENSG00000206296, ENSG00000231591, ENSG00000233089, ENSG00000233140, ENSG00000234365, ENSG00000235540 |
1 |
0.804 |
0.804 |
- |
PSMB8 antisense RNA 1 (head to head) [Source:HGNC Symbol;Acc:HGNC:39758] |
87. |
EFCAB6-AS1 |
ENSG00000223843 |
2 |
0.804 |
0.804 |
- |
EFCAB6 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:39999] |
88. |
PRSS21 |
ENSG00000007038, ENSG00000282838 |
6 |
0.804 |
0.804 |
- |
serine protease 21 [Source:HGNC Symbol;Acc:HGNC:9485] |
89. |
CTAGE1 |
ENSG00000212710, ENSG00000282841 |
10 |
0.804 |
0.804 |
- |
cutaneous T cell lymphoma-associated antigen 1 [Source:HGNC Symbol;Acc:HGNC:24346] |
90. |
CABS1 |
ENSG00000145309 |
6 |
0.804 |
0.804 |
- |
calcium binding protein, spermatid associated 1 [Source:HGNC Symbol;Acc:HGNC:30710] |
91. |
MIR4500HG |
ENSG00000228824 |
2 |
0.804 |
0.804 |
- |
MIR4500 host gene [Source:HGNC Symbol;Acc:HGNC:42773] |
92. |
C2orf83 |
ENSG00000042304 |
1 |
0.804 |
0.804 |
- |
chromosome 2 open reading frame 83 [Source:HGNC Symbol;Acc:HGNC:25344] |
93. |
PPP1R42 |
ENSG00000178125 |
2 |
0.804 |
0.804 |
- |
protein phosphatase 1 regulatory subunit 42 [Source:HGNC Symbol;Acc:HGNC:33732] |
94. |
LOC389033 |
|
6 |
0.804 |
0.804 |
- |
placenta specific 9 pseudogene |
95. |
C9orf152 |
ENSG00000188959 |
1 |
0.804 |
0.804 |
- |
chromosome 9 open reading frame 152 [Source:HGNC Symbol;Acc:HGNC:31455] |
96. |
LINC00659 |
ENSG00000228705 |
1 |
0.804 |
0.804 |
- |
long intergenic non-protein coding RNA 659 [Source:HGNC Symbol;Acc:HGNC:44316] |
97. |
TEKT2 |
ENSG00000092850 |
26 |
0.804 |
0.804 |
- |
tektin 2 [Source:HGNC Symbol;Acc:HGNC:11725] |
98. |
TUSC5 |
|
3 |
0.804 |
0.804 |
- |
tumor suppressor candidate 5 |
99. |
SLC5A9 |
ENSG00000117834 |
11 |
0.804 |
0.804 |
- |
solute carrier family 5 member 9 [Source:HGNC Symbol;Acc:HGNC:22146] |
100. |
PTGDS |
ENSG00000107317 |
1 |
0.804 |
0.804 |
- |
prostaglandin D2 synthase [Source:HGNC Symbol;Acc:HGNC:9592] |